• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number CVD0095
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Dysphagia/ Odynophagia (1815); Perforation of Esophagus (2399)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
It was reported through a research article titled "late esophageal perforation due to an amplatzer device in scimitar syndrome" that a (b)(6) man with scimitar syndrome with 2 large aortopulmonary collaterals that were causing a significant shunt.He was sent for percutaneous embolization using an amplatzer duct occluder ii device for the superior collateral and an amplatzer vascular plug for the inferior collateral, without complications.The patient remained asymptomatic for approximately 2 years with clinical follow-up every 6 months.He then reported a 3-month history of progressive dysphasia, and chest computed tomography showed partial blockage of the esophagus with the amplatzer duct occluder ii, which was completely expanded.An upper gastrointestinal endoscopy was performed, which showed that the mesh of the device was partially blocking the esophageal lumen such that the endoscope could not be advanced.Endoscopic removal of the device was performed, and a provisional esophageal stent was implanted to treat the residual stenosis.The procedure occurred without complications with no bleeding from the collaterals, which were completely occluded.The esophageal stent was removed at 3 weeks, with no residual esophageal stenosis, and the patient remained asymptomatic after discharge from hospital and at follow-up.
 
Manufacturer Narrative
As reported in a research article, a patient had the amplatzer duct occluder implanted to close a aortopulmonary collateral, which embolized after 2 years and partially blocked the esophagus.The device was removed.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER II
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10084780
MDR Text Key192153918
Report Number2135147-2020-00224
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCVD0095
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
Patient Age16 YR
-
-